- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Nxera Pharma and Shionogi Launch QUVIVIQ in Japan for Adults with Insomnia | 2 | GlobeNewswire (USA) | ||
| 29.10. | Shionogi's Xocova effective in preventing symptomatic COVID-19: study | 3 | Seeking Alpha | ||
| SHIONOGI & CO LTD ADR Aktie jetzt für 0€ handeln | |||||
| 29.10. | Shionogi & Co. reports Q2 results | 4 | Seeking Alpha | ||
| 01.10. | Nxera Pharma Enters New Commercial Partnership with Shionogi for QUVIVIQ in Japan | 213 | GlobeNewswire (Europe) | QUVIVIQ is a potential best-in-class treatment in the high-growth, dual orexin antagonist class of medicines treating sleep disorders, such as insomnia Tokyo, Japan and Cambridge, UK, 1 October 2024... ► Artikel lesen | |
| 30.07. | Earnings call: Shionogi reports mixed results, optimistic on pipeline progress | 11 | Investing.com | ||
| 09.05. | Global Health Innovative Technology Fund (GHIT Fund): Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions | 1.120 | PR Newswire | TOKYO, May 9, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.64 billion (USD 10.8 million1) in four projects... ► Artikel lesen |
6 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TRULIEVE CANNABIS | 4,888 | +5,76 % | Trulieve Cannabis Aktie: Kein Wachstum erwartet | Der Cannabis-Konzern Trulieve verzeichnet zum Jahresende eine markante Kurskorrektur an den Börsen. Mit einem aktuellen Aktienkurs von 4,624 EUR zeigt das Unternehmen eine beachtliche monatliche Einbuße... ► Artikel lesen | |
| WEST PHARMACEUTICAL SERVICES | 310,70 | -2,26 % | Looking Into West Pharmaceutical Services' Recent Short Interest | ||
| SHIONOGI | 13,700 | +1,48 % | Nxera Pharma and Shionogi Launch QUVIVIQ in Japan for Adults with Insomnia | ||
| HERITAGE CANNABIS | 0,001 | 0,00 % | Heritage Cannabis Holdings Corp.: Heritage Cannabis Announces Completion of Sale and Delisting from the CSE and the OTCQX | TORONTO, Aug. 29, 2024 /CNW/ - Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) ("Heritage" or the "Company") today announces, that, in connection with its creditor protection proceedings... ► Artikel lesen | |
| KALA BIO | 5,685 | +4,03 % | KALA BIO, Inc. - 10-Q, Quarterly Report | ||
| CHARLOTTES WEB | 0,075 | -24,37 % | Charlotte's Web Holdings, Inc.: Charlotte's Web Reports 2024 Third quarter Financial Results | Sequential quarterly growth returns for 2024 New Product Innovations Driving Omni-Channel Expansion
LOUISVILLE, Colo., Nov. 14, 2024 /PRNewswire/ - (TSX: CWEB... ► Artikel lesen | |
| BEXIMCO | 0,408 | -0,49 % | Beximco Group lays off 40,000 workers amid financial crisis | ||
| LUYE PHARMA | 0,256 | -2,29 % | LUYE PHARMA (02186): VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING IN THE COMPANY BY CONTROLLING SHAREHOLDER | ||
| GUARDION HEALTH SCIENCES | 2,740 | 0,00 % | Guardion Health Sciences, Inc.: Guardion Health Sciences Announces Filing of Certificate of Dissolution | HOUSTON, TEXAS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) ("Guardion" or the "Company") today announced that it has filed a certificate of dissolution with the... ► Artikel lesen | |
| MIRUM PHARMACEUTICALS | 40,400 | +1,51 % | Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update | FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today reported financial results for the third quarter 2024 and provided a business update.
"The Mirum team... ► Artikel lesen | |
| PERCHERON THERAPEUTICS | 0,003 | -44,44 % | XFRA AWY0: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPERCHERON THERAPEUTICS... ► Artikel lesen | |
| AYURCANN | 0,012 | 0,00 % | Ayurcann Holdings Corp.: Ayurcann Terminates Business Combination | Toronto, Ontario, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) ("Ayurcann" or the "Company"), a leading Canadian processing and manufacturing company specializing... ► Artikel lesen | |
| KALBE FARMA | 0,061 | -6,15 % | KLBF strengthens prescription drug business by inaugurating radioisotope factory: PT Kalbe Farma Tbk ... | ||
| EVEREST MEDICINES | 5,700 | -1,72 % | Everest Medicines Limited: Everest Medicines Announces the First Prescription of VELSIPITY(R) in the Greater Bay Area | - Officially Benefiting Mainland China PatientsSHANGHAI, Dec 18, 2024 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK, 'Everest', or the "Company"), a biopharmaceutical company focused on the discovery... ► Artikel lesen | |
| AVANT BRANDS | 0,314 | -5,99 % | Avant Brands Inc.: Avant Brands Announces Results for Q3 2024 | Record Gross and Net Revenue: Generated $9.6 million Gross Revenue and $8.5 million Net Revenue in Q3 2024, establishing new company records.Record Export Wholesale Revenue1: Generated $5.1 million... ► Artikel lesen |
Das Unternehmen SHIONOGI & CO LTD ADR kann der Branche Pharma zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 6,700 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHIONOGI & CO LTD ADR finden Sie auf Wallstreet Online.
